Chiome Bioscience Inc. (TYO:4583)

Chiome Bioscience Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,372	1,205	2,063	1,326	1,727	1,791
Cash & Short-Term Investments	1,372	1,205	2,063	1,326	1,727	1,791
Cash Growth	-6.98%	-41.60%	55.65%	-23.26%	-3.56%	-33.33%
Accounts Receivable	27.63	72	51.06	83.19	115.22	25.46
Other Receivables	14.92	29.52	24.43	25.05	29.57	36.05
Receivables	42.55	101.52	75.49	108.24	144.79	61.51
Inventory	72.9	49.41	46.17	64.11	71.48	59.05
Prepaid Expenses	-	55.04	46.66	43.85	57.15	34.47
Other Current Assets	245.72	135.71	106.08	87.65	91.48	270.87
Total Current Assets	1,733	1,547	2,338	1,629	2,092	2,217
Property, Plant & Equipment	35.24	36.34	-	1.17	2.44	4.2
Other Long-Term Assets	138.69	144.47	131.19	120.89	120.87	118.36
Total Assets	1,907	1,728	2,469	1,751	2,215	2,339

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	51.26	37.44	27.2	37.74	31.87	29.81
Accrued Expenses	11.84	14.56	29.56	32.32	32.91	44.46
Short-Term Debt	67.5	86.7	281.5	291	184	183
Current Income Taxes Payable	12.25	12.55	2.53	23.95	23.94	16.75
Current Unearned Revenue	60.6	130.33	-	-	-	-
Other Current Liabilities	82.04	93.31	152.65	154.03	97.74	118.53
Total Current Liabilities	285.49	374.89	493.43	539.04	370.46	392.54
Other Long-Term Liabilities	55.77	230.56	55.12	54.69	54.27	53.85
Total Liabilities	341.26	605.44	548.55	593.73	424.72	446.39

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,555	1,086	995.53	2,388	2,097	1,516
Retained Earnings	8.19	22.24	915.02	-1,248	-319.53	342.02
Treasury Stock	-0.31	-0.29	-0.29	-0.29	-0.29	-0.29
Comprehensive Income & Other	3.28	14.59	10.05	17.74	13.55	35.4
Total Common Equity	1,566	1,122	1,920	1,158	1,791	1,893
Shareholders' Equity	1,566	1,122	1,920	1,158	1,791	1,893
Total Liabilities & Equity	1,907	1,728	2,469	1,751	2,215	2,339

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	67.5	86.7	281.5	291	184	183
Net Cash (Debt)	1,305	1,118	1,782	1,035	1,543	1,608
Net Cash Growth	7.42%	-37.23%	72.23%	-32.96%	-4.03%	-35.84%
Net Cash Per Share	18.49	16.47	30.61	20.88	35.09	39.92
Filing Date Shares Outstanding	78.92	68.44	66.96	52.63	48.42	40.78
Total Common Shares Outstanding	78.92	68.44	66.96	52.63	48.42	40.78
Working Capital	1,448	1,172	1,844	1,090	1,722	1,824
Book Value Per Share	19.84	16.39	28.68	22.00	36.98	46.42
Tangible Book Value	1,566	1,122	1,920	1,158	1,791	1,893
Tangible Book Value Per Share	19.84	16.39	28.68	22.00	36.98	46.42
Machinery	327.69	329.98	312.86	318.96	351.63	387.39

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error